Atea Pharmaceuticals, Inc.
AVIR· Nasdaq
Released Mar 30, 2021, after the close
10-K filed Mar 30, 2021, 89 days after period end · 0001564590-21-016724
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|
| Net Income | $20.66M | -$4.66M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Atea Pharmaceuticals, Inc. · CIK 1593899 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 30, 2021 · 89 d after period end
+9.8% from the close of Mar 30, 2021 to the close of Mar 31, 2021, the first after the release.